Search

Thermo Fisher Scientific Inc

Suletud

SektorTervishoid

699.76 0.03

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

696.93

Max

700.44

Põhinäitajad

By Trading Economics

Sissetulek

-14M

1.7B

Müük

143M

12B

P/E

Sektori keskmine

38.061

68.089

Aktsiakasum

6.68

Dividenditootlus

0.26

Kasumimarginaal

14.229

Töötajad

125,000

EBITDA

-399M

2.5B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+9.71% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.26%

1.98%

Järgmine tulemuste avaldamine

28. jaan 2027

Järgmine dividendimakse kuupäev

15. jaan 2027

Järgmine aktsia dividendi kuupäev (ex-date)

15. dets 2026

Turustatistika

By TradingEconomics

Turukapital

16B

267B

Eelmine avamishind

699.73

Eelmine sulgemishind

699.76

Thermo Fisher Scientific Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. nov 2026, 23:36 UTC

News

Thermo Fisher Scientific CEO Marc N. Casper will participate in the UBS 2026 CEO Call Series on November 19, 2026, at 8:30 a.m. ET.

12. nov 2026, 23:01 UTC

Thermo Fisher Scientific Inc. is trading modestly higher in after-market hours, reaching its highest point of the day and remaining above its 20-day moving average.

11. nov 2026, 23:01 UTC

Thermo Fisher Scientific Inc. is trading higher in after-market hours, recovering from a low point and surpassing its 20-day moving average.

10. nov 2026, 21:07 UTC

Correlated Moves
Macro Event

Thermo Fisher Scientific Inc. shares fell amid a broader decline in the Life Sciences Tools & Services sector, influenced by recent U.S. inflation data.

9. nov 2026, 21:04 UTC

Thermo Fisher Scientific Inc. is gaining during Monday's trading session, breaking from a recent trend of higher daily closes since Friday's close.

6. nov 2026, 21:03 UTC

Correlated Moves

Thermo Fisher Scientific Inc. is advancing, reflecting positive market momentum, while Charles River Laboratories rises sharply after an upgrade from Mizuho analyst Ann Hynes.

5. nov 2026, 23:03 UTC

News

Thermo Fisher Scientific announces a $5 billion share repurchase program and declares a quarterly cash dividend of $0.47 per share, payable January 15, 2027.

4. nov 2026, 23:11 UTC

Thermo Fisher Scientific Inc. is trading higher in after-market hours, reaching its highest point of the day and maintaining performance above the 20-day moving average.

3. nov 2026, 20:56 UTC

Correlated Moves

Revvity, Inc. shares are sharply higher following strong third-quarter results that surpassed analyst expectations, with Thermo Fisher Scientific Inc. moving in sympathy.

2. nov 2026, 23:16 UTC

News

Thermo Fisher Scientific Inc. has a market capitalization of $262.95 billion, with shares advancing in after-market trading following earlier declines.

30. okt 2026, 20:08 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are declining amid a broader downturn in the Life Sciences Tools & Services sector, despite earlier rebounding from a low.

29. okt 2026, 23:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. is trading modestly higher in after-market hours, alongside significant gains in the Life Sciences Tools & Services sub-sector.

28. okt 2026, 20:07 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are advancing, reflecting a broader positive trend alongside Charles River Laboratories, despite an earlier pullback from a session high.

27. okt 2026, 23:06 UTC

Correlated Moves

Thermo Fisher Scientific Inc. is trading modestly higher in after-market hours, moving in sympathy with Danaher Corporation, which is also showing strength.

26. okt 2026, 23:41 UTC

Thermo Fisher Scientific Inc. is trading modestly lower in after-market hours, having experienced a cumulative decline while remaining above its 20-day moving average.

23. okt 2026, 22:01 UTC

Thermo Fisher Scientific Inc advanced during after-market hours, reaching a cumulative return of nearly 1% since Friday's close, remaining above its 20-day moving average.

22. okt 2026, 23:01 UTC

News

Citi analyst Patrick Donnelly raised the price target on Thermo Fisher Scientific to $800 from $685 while maintaining a Buy rating.

21. okt 2026, 20:03 UTC

Social Media
News
Correlated Moves
Event

Thermo Fisher Scientific's price target raised to $785 from $630 by Jefferies, following strong Q3 earnings of $6.68 per share and revenue of $12.137 billion.

20. okt 2026, 23:21 UTC

Thermo Fisher Scientific Inc. is trading modestly higher in after-market hours, reaching its highest cumulative return since Tuesday's close.

19. okt 2026, 23:06 UTC

Thermo Fisher Scientific Inc shares declined modestly during after-market hours, following a broader market drop amid challenges reflected in the NAHB Housing Market Index.

16. okt 2026, 23:46 UTC

Thermo Fisher Scientific Inc is advancing in after-market trading, showing a modest increase since Friday's close and remaining above its 20-day moving average.

15. okt 2026, 20:03 UTC

News
Event

Thermo Fisher Scientific is set to report Q3 FY2026 earnings on October 21, with EPS estimated at $6.40 and revenue at $11.9 billion.

14. okt 2026, 23:41 UTC

Thermo Fisher Scientific Inc. is trading modestly higher in after-market hours, marking its sixth consecutive session of gains and reaching its highest level of the day.

13. okt 2026, 23:01 UTC

Thermo Fisher Scientific Inc. is trading modestly lower in after-market hours, retracing from an early high shortly after the market closed.

12. okt 2026, 23:06 UTC

Thermo Fisher Scientific Inc saw a modest increase in after-market trading, with its price near the upper end of its one-month range.

9. okt 2026, 20:07 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are modestly higher, influenced by positive movement in the broader life sciences sector, with Repligen Corp advancing sharply.

8. okt 2026, 23:05 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are modestly lower in after-market trading, moving in sympathy with Danaher Corp amid unusual trading behavior.

7. okt 2026, 20:07 UTC

News

Thermo Fisher Scientific shares rose modestly as Barclays analyst Luke Sergott raised the price target to $750 from $650, maintaining an Overweight rating.

6. okt 2026, 23:15 UTC

Thermo Fisher Scientific Inc. traded modestly higher in after-market hours, recovering from an initial dip and remaining above its 20-day moving average.

5. okt 2026, 20:01 UTC

Correlated Moves

Thermo Fisher Scientific Inc is advancing, continuing its upward trajectory since Friday, supported by stronger performance in the Life Sciences Tools & Services sector.

Võrdlus sarnastega

Hinnamuutus

Thermo Fisher Scientific Inc Prognoos

Hinnasiht

By TipRanks

9.71% tõus

12 kuu keskmine prognoos

Keskmine 768.176 USD  9.71%

Kõrge 830 USD

Madal 650 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Thermo Fisher Scientific Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

15

Osta

3

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat